| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3407056 | F | Antibacterial activity against Staphylococcus epidermidis ATCC 12228 at 100 ug after 24 hrs | Staphylococcus epidermidis | 1 | ALA3400138 | organism-based format | Scientific Literature | |
| 2. | ALA3407057 | F | Antibacterial activity against Staphylococcus aureus ATCC 25923 at 100 ug after 24 hrs | Staphylococcus aureus | 2 | ALA3400138 | organism-based format | Scientific Literature | |
| 3. | ALA3407058 | F | Antibacterial activity against Escherichia coli ATCC 25922 at 100 ug after 24 hrs | Escherichia coli | 3 | ALA3400138 | organism-based format | Scientific Literature | |
| 4. | ALA3407060 | A | Cytotoxicity against rat L6 cells after 72 hrs by alamar blue assay | Rattus norvegicus | 23 | ALA3400138 | cell-based format | Scientific Literature | |
| 5. | ALA3407061 | F | Antiplasmodial activity against chloroquine and pyrimethamine resistant Plasmodium falciparum K1 infected in human red blood cells assessed as reduction in parasite viability after 48 hrs by [3H]-hypoxanthine incorporation assay | Plasmodium falciparum | 21 | ALA3400138 | organism-based format | Scientific Literature | |
| 6. | ALA3407062 | F | Selectivity index, ratio of CC50 for rat L6 cells to IC50 for chloroquine and pyrimethamine resistant Plasmodium falciparum K1 | 21 | ALA3400138 | cell-based format | Scientific Literature | ||
| 7. | ALA3407063 | F | Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB900 bloodstream forms after 72 hrs by alamar blue assay | Trypanosoma brucei rhodesiense | 21 | ALA3400138 | organism-based format | Scientific Literature | |
| 8. | ALA3407064 | F | Selectivity index, ratio of CC50 for rat L6 cells to IC50 for Trypanosoma brucei rhodesiense STIB900 | 21 | ALA3400138 | cell-based format | Scientific Literature | ||
| 9. | ALA3407065 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction in parasitemia at 50 mg/kg, ip administered 4, 24, 48 and 72 hrs post infection by FACS analysis | Plasmodium berghei | 3 | ALA3400138 | organism-based format | Scientific Literature | |
| 10. | ALA3407208 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction in parasitemia at 10 mg/kg, ip administered 4, 24, 48 and 72 hrs post infection by FACS analysis | Plasmodium berghei | 2 | ALA3400138 | organism-based format | Scientific Literature | |
| 11. | ALA3407209 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction in parasitemia at 20 mg/kg, ip administered 4, 24, 48 and 72 hrs post infection by FACS analysis | Plasmodium berghei | 1 | ALA3400138 | organism-based format | Scientific Literature | |
| 12. | ALA3407210 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction in parasitemia at 100 mg/kg, po administered 4, 24, 48 and 72 hrs post infection by FACS analysis | Plasmodium berghei | 1 | ALA3400138 | organism-based format | Scientific Literature | |
| 13. | ALA3407211 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction in parasitemia at 100 mg/kg, po administered 24 hrs post infection by FACS analysis | Plasmodium berghei | 1 | ALA3400138 | organism-based format | Scientific Literature | |
| 14. | ALA3407212 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction in parasitemia at 200 mg/kg, po administered 24 hrs post infection by FACS analysis | Plasmodium berghei | 1 | ALA3400138 | organism-based format | Scientific Literature | |
| 15. | ALA3407213 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as mean survival day at 50 mg/kg, ip administered 4, 24, 48 and 72 hrs post infection (Rvb = 4 to 6 days) | Plasmodium berghei | 3 | ALA3400138 | organism-based format | Scientific Literature | |
| 16. | ALA3407214 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as mean survival day at 10 mg/kg, ip administered 4, 24, 48 and 72 hrs post infection (Rvb = 4 days) | Plasmodium berghei | 2 | ALA3400138 | organism-based format | Scientific Literature | |
| 17. | ALA3407215 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as mean survival day at 20 mg/kg, ip administered 4, 24, 48 and 72 hrs post infection (Rvb = 4 days) | Plasmodium berghei | 1 | ALA3400138 | organism-based format | Scientific Literature | |
| 18. | ALA3407216 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as mean survival day at 100 mg/kg, po administered 4, 24, 48 and 72 hrs post infection (Rvb = 4 days) | Plasmodium berghei | 1 | ALA3400138 | organism-based format | Scientific Literature | |
| 19. | ALA3407217 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as mean survival day at 100 mg/kg, po administered 24 hrs post infection (Rvb = 3 days) | Plasmodium berghei | 1 | ALA3400138 | organism-based format | Scientific Literature | |
| 20. | ALA3407218 | F | Antiplasmodial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as mean survival day at 200 mg/kg, po administered 24 hrs post infection (Rvb = 3 days) | Plasmodium berghei | 1 | ALA3400138 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!